Loading
Matthew Gline received $163.3M in total compensation as Chief Executive Officer of Roivant Sciences Ltd. in FY2024. The largest component was $157.6M in stock awards. That’s up 22021% from FY2023. Source: SEC DEF 14A.
In fiscal year 2024, Matthew Gline, Chief Executive Officer of Roivant Sciences Ltd. (ROIV), received total compensation of $163.3 million.
Matthew Gline's compensation breakdown includes: base salary of $725K, bonus of $5.0 million, stock awards valued at $157.6 million, and other compensation of $12K.
Compared to fiscal year 2023, Matthew Gline's total compensation increased 22021% from $738K to $163.3 million.
Roivant Sciences Ltd.'s top 6 named executive officers received combined total compensation of $438.2 million in fiscal year 2024.
The named executive officers disclosed in Roivant Sciences Ltd.'s 2024 proxy statement are:Matthew Gline (Chief Executive Officer) with total compensation of $163.3 million, Eric Venker (President and Immunovant CEO) with total compensation of $11.8 million, Mayukh Sukhatme (President and Chief Investment Officer) with total compensation of $251.9 million, Rakhi Kumar (Chief Accounting Officer) with total compensation of $4.7 million, Richard Pulik (Chief Financial Officer) with total compensation of $4.1 million, and Jennifer Humes (Chief Accounting Officer) with total compensation of $2.4 million.
Source Filing
Executive Record
Matthew Gline
Chief Executive Officer
Reported Pay
$163.3M
Summary compensation table total · FY2024
Findings
Reviewing FY2024 compensation of $163.3M against +5% shareholder return and the latest filing-backed pay disclosures.
Reported pay changed +999%; spread versus stock performance is pending computation.
Evidence is sourced from the latest executive compensation filing and return series for ROIV.
Team view
6 executives
Chief Executive Officer
Total PayFY2024
$163.3M
President and Immunovant CEO
Total PayFY2024
$11.8M
President and Chief Investment Officer
Total PayFY2024
$251.9M
Chief Accounting Officer
Total PayFY2024
$4.7M
Chief Financial Officer
Total PayFY2024
$4.1M
Chief Accounting Officer
Total PayFY2024
$2.4M
Ask a question about this filing
01FY2024 total compensation breakdown
$163.3M total compensation
Matthew Gline earned $163.3M in FY2024 — here's how that breaks down.
$157.6M
96% of total
$5.0M
3% of total
$725.0K
0% of total
$12.0K
0% of total
A pay-performance summary will appear here once the verdict loads above.
02Pay changes vs. stock performance
1 year of data
Peer context
Dashed line marks the large-cap median compensation benchmark for companies around $21.0B market cap, based on 312 peers in this size band.
03Recent insider trades by officers and directors
~32 trades
04Showing FY2025 data (latest available)
FY2026 does not include director compensation in our current dataset, so we're showing the latest board table we found.
We're loading the latest director compensation and board makeup.
05Take action on executive compensation
Shareholder activism tools
Start or join campaigns to engage with ROIV's board on executive compensation, governance, and shareholder proposals.
Activism Beta — Sign in to start or join campaigns
06For analysts and deep research
Historical compensation data from latest proxy filing
| Year | Executive | Salary | Bonus & Incentive | Stock Awards | Option Awards | Other Adj. | Total |
|---|---|---|---|---|---|---|---|
| 2024 | Matthew Gline Chief Executive Officer | $0.73M | $4.98M | $157.6M | $0.00M | $0.01M | $163.3M |
| 2023 | Matthew Gline Chief Executive Officer | $0.73M | $0.00M | $0.00M | $0.00M | $0.01M | $0.74M |
| 2022 | Matthew Gline Chief Executive Officer | $0.73M | $1.04M | $0.00M | $47.2M | $0.01M | $49.0M |
Salary = base cash pay. Bonus & Incentive combines annual bonus and non-equity plans. Equity amounts are grant-date fair values. Other Adj. captures pension changes, perquisites, and any reconciliation items so the total matches the reported figure.
Get one email when new executive compensation data is filed and processed.
Roivant Sciences Ltd. (ROIV) — Key Facts
Last updated Apr 4, 2026 · DEF 14A filed Jul 29, 2025
| CEO | Matthew Gline, Chief Executive Officer |
|---|---|
| Fiscal year | FY2024 |
| Total compensation | $163.3M |
| Base salary | $725K |
| Stock awards | $157.6M |
| Other compensation | $12K |
| Year-over-year change | +22021% |
| Source | DEF 14A, 2025-07-29 |
Matthew Gline, the Chief Executive Officer of Roivant Sciences Ltd., received total compensation of $163.3 million in fiscal year 2024. This includes base salary of $725,000 and stock awards valued at $157.6 million.
Matthew Gline's base salary at Roivant Sciences Ltd. is $725,000 per year as of fiscal year 2024. However, total compensation including stock awards, bonuses, and other benefits is $163.3 million.
Roivant Sciences Ltd.'s CEO, Matthew Gline, earned $163.3 million in total compensation for fiscal year 2024. The majority of this compensation comes from stock awards ($157.6 million) rather than base salary ($725,000).